BETA - CAROTENE AND CANCER
The subject β-carotene and cancer has been studied for more than twenty years, through epidemiologic and experimental researches.Observational epidemiologic studies, both prospective and retrospective, have suggested strongly that high intake of vegetables and fruits which are sources of β-carotene...
| Autor: | |
|---|---|
| Tipo de recurso: | artículo |
| Estado: | Versión publicada |
| Fecha de publicación: | 1998 |
| País: | Brasil |
| Institución: | Pontifícia Universidade Católica de Campinas (PUC-CAMPINAS) |
| Repositorio: | Revista de Nutrição |
| Idioma: | portugués |
| OAI Identifier: | oai:ojs.periodicos.puc-campinas.edu.br:article/8571 |
| Acceso en línea: | https://periodicos.puc-campinas.edu.br/nutricao/article/view/8571 |
| Access Level: | acceso abierto |
| Palabra clave: | nutritional epidemiology chemoprevention neoplasms experimental carcinogens carotenoids beta-carotene epidemiologia nutricional quimioprevenção neoplasias carcinógenos carotenóides beta-caroteno |
| Sumario: | The subject β-carotene and cancer has been studied for more than twenty years, through epidemiologic and experimental researches.Observational epidemiologic studies, both prospective and retrospective, have suggested strongly that high intake of vegetables and fruits which are sources of β-carotene is associated with reduced risk of cancer, specially of lung cancer. However, the results of intervention trials do not demonstrate a preventive potential of β-carotene. Nevertheless, in many studies in experimental animals and in cell cultures, this carotenoid had been shown to act as a potent cancer chemopreventive agentand mechanisms have been proposed to explain this protective effect on biological systems. Researchers suggest that β-carotene protects against cancer, in the amounts easily attained by the consumption of a wide variety of diets, and the chronic pharmacological supplementation is not recommended for healthy populations and for heavy smokers. |
|---|